Concepedia

A. M. Burgess

AM

Statistics

Publications

5

Citations

131

H-Index

5

Active since

1980

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Indiana University – Purdue University Indianapolis

Walther Cancer Foundation

A. M. Burgess is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, pharmacology, and pharmacotherapy.

Top concepts

Publications per year

1980–2003

5

Publications

5

Importance of Predosing of Recombinant Human Thrombopoietin to Reduce Chemotherapy-Induced Early Thrombocytopenia

Saroj Vadhan‐Raj, Shreyaskumar Patel, Carlos Bueso-Ramos et al. · Journal of Clinical Oncology · 2003 · 68 citations

In vivo biologic effects of PIXY321, a synthetic hybrid protein of recombinant human granulocyte-macrophage colony-stimulating factor and interleukin-3 in cancer patients with normal hematopoiesis: a phase I study

Saroj Vadhan‐Raj, HE Broxmeyer, Michael Andreeff et al. · Blood · 1995 · 27 citations · Full text

Phase I clinical study of N-(phosphonacetyl)-L-aspartic acid (PALA).

Manuel Valdivieso, Ellen Moore, A. M. Burgess et al. · PubMed · 1980 · 14 citations

, , +3

Initial clinical studies of vindesine.

Manuel Valdivieso, Stephen P. Richman, A. M. Burgess et al. · PubMed · 1981 · 12 citations

, , +10

Effect of cyclophosphamide on the mitomycin-induced syndrome of thrombotic thrombocytopenic purpura.

Verena Hug, A. M. Burgess, G. R. Blumenschein et al. · PubMed · 1985 · 10 citations

, , +5

Rows per page

1–5 of 5